The absorption of human calcitonin from the transverse colon of man

International Journal of Pharmaceutics

Volumn 130, Issue 1, 1996, Pages 33-39

  Antonin, K H ^a   Rak, R ^a   Bieck, P R ^a   Preiss, R ^b   Schenker, U ^b   Hastewell, J ^c   Fox, R ^d   Mackay, M ^e  

^a Ciba Holding Deutschland GmbH   (Germany)

^b UNIVERSITY OF LEIPZIG   (Germany)

^c Ciba Pharmaceuticals   (United Kingdom)

^d Ciba Pharmaceuticals   (United Kingdom)

^e CIBA GEIGY LTD   (Switzerland)

Author keywords

Absorption; Colon; Human calcitonin; Human study; Loop stoma; Oral drug delivery

Indexed keywords

CALCITONIN;

ABDOMINAL DISCOMFORT; ADULT; AGED; ARTICLE; BIOAVAILABILITY; CLINICAL ARTICLE; CLINICAL TRIAL; COLON ABSORPTION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG ABSORPTION; DRUG BLOOD LEVEL; FEMALE; HEADACHE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; NAUSEA; PRIORITY JOURNAL; STOMA; TRANSVERSE COLON;

EID: 0029877034     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/0378-5173(95)04248-2     Document Type: Article

References (17)

1. Antonin, K.H., Saano, V., Bieck, P., Hastewell, J., Fox, R., Lowe, P. and Mackay, M., Colonic absorption of human calcitonin in man. Clin. Sci., 83 (1992) 627-631.
2. Austin, L.A. and Heath, H., Calcitonin, physiology and pathophysiology. N. Engl. J. Med., 304 (1981) 269-278.
3. Beglinger, C., Born, W., Muff, R., Drewe, J., Dreyfuss, J.L., Bock, A., Mackay, M. and Fischer, J.A., Intracolonic bioavailability of human calcitonin in man. Eur. J. Pharmacol., 43 (1992) 527-531.
4. Cummings, J.H., Banwell, J.G., Segal, I., Coleman, N., Englyst, H.N. and Macfarlane, G.T., The amount and composition of large bowel contents in man. Gastroenterology, 98 (1990) A408.
5. Gennari, C., Passeri, M., Chierichetti, S.M. and Piolini, M., Side effects of synthetic salmon and human calcitonin. Lancet, (i) (1983) 594-595.
6. Greenberg, P.B., Doyle, F.H., Fisher, M.T., Hillyard, C.J., Joplin, G.F., Pennock, J. and MacIntyre, I., Treatment of Paget's disease of bone with synthetic human calcitonin. Am. J. Med., 56 (1974) 867-871.
7. Hastewell, J., Lynch, S., Fox, R., Williamson, I., Skelton-Stroud, P and Mackay, M., Enhancement of human calcitonin absorption across the rat colon in vivo. Int. J. Pharm., 101 (1994) 115-120.
8. Hastewell, J., Lynch, S., Williamson, I., Fox, R. and Mackay, M., Absorption of human calcitonin across the rat colon. Clin. Sci., 82 (1992) 589-594.
9. Mackay, M., Delivery of recombinant peptide and protein drugs. Biotechnol. Genet. Eng. Rev., 8 (1991) 251-278.
10. Mackay, M. and Tomlinson, E., Colonic delivery of therapeutic polypeptides and proteins. In Bieck, P.R. (Ed.), Colonic Drug Absorption and Metabolism. Marcel Dekker, New York, 1993, pp. 159-176.
11. McDermott, M.T. and Kidd, G.S., The role of calcitonin in the development and treatment of osteoporosis. Endocrine Rev., 8 (1987) 377-390.
12. 15N-labelled urea in the functioning and defunctioned human colon. Clin. Sci., 79 (1990) 253-258.
13. Muff, R., Dambacher, M.A., Perrenould, A., Simon, C. and Fischer, J.A., Efficacy of intranasal human calcitonin in patients with Paget's disease refractory to salmon calcitonin. Am. J. Med., 89 (1990) 181-184.
14. O'Doherty, D.P., Bickerstaff, D.R., McCloskey, E.V., Atkins, R., Hamdy, N.A.T. and Kanis, J.A., A comparison of the acute effects of subcutaneous and intranasal calcitonin. Clin. Sci., 78 (1990) 215-219.
15. Reginster, J.Y., Albert, A. and Franchimont, P., Salmon-calcitonin nasal spray in Paget's disease in bone: preliminary results in five patients. Calcif. Tissue Int., 37 (1985) 577-561.
16. Ritschel, W.A., Targeting to the gastrointestinal tract: new approaches. Methods Find. Exp. Clin. Pharmacol., 13 (1991) 313-336.
17. Stevenson, J.C. and Evans, I.M., Pharmacology and therapeutic use of calcitonin. Drugs, 21 (1981) 257-272.